Skip to content

Changes of lymphocyte subsets and cytokines in patients with liver malignant tumor after microwave ablation treatment

Changes of lymphocyte subsets and cytokines in patients with liver malignant tumor after microwave ablation treatment

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-ICR-15006187
Enrollment
Unknown
Registered
2015-03-30
Start date
2013-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cancer

Interventions

Sponsors

401th Hospital of People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
42 Years to 76 Years

Inclusion criteria

Inclusion criteria: 1. patients with hepatocellular carcinom; 2. age 42-76; 3. lesion diameter 1-10.8cm.

Exclusion criteria

Exclusion criteria: 1. other parts of the coexistence of tumor; 2. tumor could not be complete ablation by once; 3. during the study period with severe liver and kidney dysfunction, coagulation disorders and diseases of the immune system; 4. patients had received operation, intervention, radiotherapy, chemotherap, immune enhancement agen before and after the treatment of 1 months; 5. participating in other clinical trials of patient; 6. the researchers believe that any reason will causes the patients to be unsuitable for clinical trials.

Design outcomes

Primary

MeasureTime frame
regulatory T cell;natural killer cell;CD4+ T cell;CD8+ T cell;TNF-alpha;IFN-gama;IL-2;IL-4;IL-6;IL-8;IL-10;IL-12;

Countries

China

Contacts

Public ContactZhuang Xingjun
401zxj@163.com+86 13361290286

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026